Concepedia

Stanley C. Chamberlain

SC

2

Publications

463

Citations

2

H-Index

2002

Active since

Affiliations

Research Triangle Park Foundation(Current)

University of Michigan

GlaxoSmithKline (United States)

Stanley C. Chamberlain is an author at Research Triangle Park Foundation specializing in drug resistance, virology, and drug discovery.

Top concepts

Publications per year

2002–2002

2

Publications

2

Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole <scp>l</scp> -Riboside with a Unique Mode of Action

Karen K. Biron, Richard J. Harvey, Stanley C. Chamberlain et al. · Antimicrobial Agents and Chemotherapy · 2002 · 361 citations · Full text

, , +18

Preclinical and Toxicology Studies of 1263W94, a Potent and Selective Inhibitor of Human Cytomegalovirus Replication

George W. Koszalka, Nelson Johnson, Steven S. Good et al. · Antimicrobial Agents and Chemotherapy · 2002 · 102 citations · Full text

Rows per page

1–2 of 2